Interstitial Lung Disease in Children: Rare Genetic Variants Beyond Surfactant Dysfunction
Pediatric Pulmonology · 2026-08 · 61 (8)
DOI: 10.1002/ppul.71791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 14.08.2026. Verfasst von Satı Özkan Tabakçı und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Pulmonology, Ankara Bilkent City Hospital, Ankara, Türkiye. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Genetic Variation. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Advances in genetic analysis techniques and strategies have enabled the identification of rare novel genetic entities in children's interstitial lung disease (chILD).
Aims
To describe an extensive array of demographic, clinical, radiological, and laboratory data from a national registry of children with diffuse lung disease caused by rare and novel genetic variants. Study Design Retrospective cohort study.
Methods
This study used data from the chILD Türkiye (chILD‐TR) registry to analyze rare genetic chILD subtypes, excluding surfactant protein gene variants, ABCA3 , and NKX2‐1 , between November 2021 and January 2024. Of 671 patients in chILD‐TR, 182 underwent genetic analysis excluding surfactant protein‐related variants, resulting in 37 patients identified with rare genetic variants included in the study.
Results
Among the 37 patients with rare genetic variants, 19 (51.4%) were male, and the median age at diagnosis was 40.5 months (IQR 15.5–115.5). Genetic analysis conducted on 15 patients identified COPA , STAT3 , STING1 , ADA , ZNFX1 , PIK3CD , PLCG2 , OAS1, CCR2, RNF168 and ATM gene variants, which are associated with immunodeficiency/dysregulation and autoinflammation; 15 NPC1 , SMPD1 , GBA1 , SLC7A7 , MARS1 , FARSB , and PEPD genes, variants linked to inherent metabolic errors. Seven patients were found with TBX4 , SLC34A2 , PLG , and SMAD4 gene variants. All patients were born at term, and five (13.5%) of them were small for gestational age. Two patients (5.4%) had previously been on a mechanical ventilator in the neonatal intensive care unit, 25(67.6%) had familial consanguinity, and 23 (62.1%) had comorbid systemic disease. Thirteen patients (35.1%) required oxygen support. All patients underwent chest computed tomography scans at initial assessment, showing ground‐glass opacities in 29 (78.3%), infiltrations in 27 (72.9%), and interlobular septal thickening in 20 (54%). Eight patients (21.6%) received oral steroids, and six (16.2%) received pulse steroids in addition to their primary treatments for systemic diseases.
Conclusions
Interstitial lung disease rarely occurs in children, but increased awareness and genetic testing may enable earlier diagnosis. Recognizing that diffuse parenchymal lung disease can occur in rare systemic diseases may improve diagnoses and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Pulmonology, Ankara Bilkent City Hospital, Ankara, Türkiye.
- Faculty of Medicine, Department of Pediatric Pulmonology, Ankara Yıldırım Beyazıt University, Ankara, Türkiye.
- Department of Medical Genetics, Ankara Bilkent City Hospital, Ankara, Türkiye.
- Faculty of Medicine, Department of Pediatric Pulmonology, Hacettepe University, Ankara, Türkiye.
- Faculty of Medicine, Department of Pediatric Pulmonology, Medeniyet University, İstanbul, Türkiye.
- Cerrahpaşa Faculty of Medicine, Department of Pediatric Pulmonology, İstanbul University-Cerrahpaşa, İstanbul, Türkiye.
ORCID-Profile: Satı Özkan Tabakçı, Şule Selin Akyan Soydaş, Gökçen Dilşa Tuğcu, Güzin Cinel, Ayşe Ceren Sağdıç, Uğur Özçelik, Sinem Can Oksay, Çiğdem Korkmaz, Fazılcan Zirek, Handan Kekeç, Figen Gülen, Melih Hangül, Beste Özsezen, Derya Ufuk Altıntaş, Hanife Tuğçe Çağlar, A Erdem Başaran, Zeynep Seda Uyan, Ali Özdemir, Tuğba Ramaslı Gürsoy, Ebru Yalçın, Nagehan Emiralioğlu, Saniye Girit, Ayşe Ayzıt Kılınç, Nazan Çobanoğlu, Tuğba Şişmanlar Eyüboğlu, Sevgi Pekcan, Yasemin Gökdemir, Berna Oğuz, Diclehan Orhan, Ahmet Cevdet Ceylan, Nural Kiper
Zitieren
APA
Tabakçı, S. Ö., Akyan Soydaş, Ş. S., Tuğcu, G. D., Cinel, G., Sağdıç, A. C., Özçelik, U., Can Oksay, S., Korkmaz, Ç., Zirek, F., Kekeç, H., Gülen, F., Hangül, M., Özsezen, B., Altıntaş, D. U., Çağlar, H. T., Başaran, A. E., Uyan, Z. S., Özdemir, A., Ramaslı Gürsoy, T., …, & Kiper, N. (2026). Interstitial Lung Disease in Children: Rare Genetic Variants Beyond Surfactant Dysfunction. Pediatric Pulmonology, 61(8). https://doi.org/10.1002/ppul.71791
Vancouver
Tabakçı SÖ, Akyan Soydaş ŞS, Tuğcu GD, Cinel G, Sağdıç AC, Özçelik U, et al. Interstitial Lung Disease in Children: Rare Genetic Variants Beyond Surfactant Dysfunction. Pediatric Pulmonology. 2026;61(8). doi:10.1002/ppul.71791
BibTeX
@article{Tabak2026,
author = {Tabakçı, Satı Özkan and Akyan Soydaş, Şule Selin and Tuğcu, Gökçen Dilşa and Cinel, Güzin and Sağdıç, Ayşe Ceren and Özçelik, Uğur and Can Oksay, Sinem and Korkmaz, Çiğdem and Zirek, Fazılcan and Kekeç, Handan and Gülen, Figen and Hangül, Melih and Özsezen, Beste and Altıntaş, Derya Ufuk and Çağlar, Hanife Tuğçe and Başaran, A Erdem and Uyan, Zeynep Seda and Özdemir, Ali and Ramaslı Gürsoy, Tuğba and Yalçın, Ebru and Emiralioğlu, Nagehan and Girit, Saniye and Kılınç, Ayşe Ayzıt and Çobanoğlu, Nazan and Şişmanlar Eyüboğlu, Tuğba and Pekcan, Sevgi and Gökdemir, Yasemin and Oğuz, Berna and Orhan, Diclehan and Ceylan, Ahmet Cevdet and Kiper, Nural},
title = {Interstitial Lung Disease in Children: Rare Genetic Variants Beyond Surfactant Dysfunction},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {8},
doi = {10.1002/ppul.71791}
}
EUVIMED